Cleared Traditional

K160186 - EnSite Velocity Surface Electrode Kit

K160186 is an FDA 510(k) clearance for EnSite Velocity Surface Electrode Kit, manufactured by St Jude Medical. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 254-day FDA review.

K160186 · St Jude Medical · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2016
Decision
254d
Days
Class 2
Risk

K160186 is an FDA 510(k) clearance for the EnSite Velocity Surface Electrode Kit. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by St Jude Medical (St. Paul, US). The FDA issued a Cleared decision on October 7, 2016 after a review of 254 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all St Jude Medical devices

FDA 510(k) Submission Details - K160186

510(k) Number K160186 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 27, 2016
Decision Date October 07, 2016
Days to Decision 254 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
129d slower than avg
Panel avg: 125d · This submission: 254d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 370
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K160186.
MediGuide Technology System
K162643 · St Jude Medical · Dec 2016
CardioInsight Cardiac Mapping System
K162440 · Cardioinsight Technologies, Inc. · Nov 2016
Ensite Velocity Cardiac Mapping System v5.0, Ensite Automap Module v1.0
K160187 · St Jude Medical · Oct 2016
Sentry WEB SmartInterp
K153654 · Carefusion Germany 234 GmbH · Sep 2016
CardioConfirm
K161465 · Mortara Instrument, Inc. · Sep 2016
Rhythm View Workstation (non-streaming)
K161240 · Abbott Electrophysiology · Aug 2016